General practitioner recognition of mental illness in the absence of a 'gold standard'

The Australian and New Zealand Journal of Psychiatry
Mental Health and General Practice Investigation (MaGPIe) Research Group

Abstract

To compare general practitioner (GP) recognition of mental illness with cases identified by screening and diagnostic instruments. Cross-sectional survey (part of the Mental Health and General Practice Investigation [MaGPIe] study) set in the lower North Island of New Zealand. The study sample consisted of consecutive patients from a random sample of GPs who were screened using the General Health Questionnaire (GHQ-12). Based on GHQ scores a stratified random sample of patients was selected and invited to participate in an in-depth interview to assess their psychological health and a subsequent longitudinal study. GPs assessed patients' psychological health using a 5-point scale of severity. Patients completed the GHQ-12, Composite International Diagnostic Interview (CIDI), Somatic and Psychological Health Report (SPHERE-12) and World Health Organization's Disability Assessment Schedule Version II (WHODAS). Seventy GPs (90% response) and 775 patients (70% response) were included in analyses. Overall, GPs recognized symptoms of psychological disorders in the past 12 months in 56.4% (95% CI=49.3-63.5) of patients. Agreement between GP rates of recognition of mental disorders and diagnostic or symptom rating instruments varied depe...Continue Reading

References

Aug 1, 1991·Archives of General Psychiatry·J OrmelG van de Willige
Feb 1, 1988·Journal of Cardiothoracic Anesthesia·J S Goldberg
Sep 1, 1988·General Hospital Psychiatry·J F BorusW W Livingston
Jun 1, 1985·Archives of General Psychiatry·L G KesslerJ D Burke
Aug 1, 1981·Journal of Experimental Child Psychology·A P Copeland, N M Wisniewski
Jan 1, 1995·Journal of Psychiatric and Mental Health Nursing·T Hostick
Mar 17, 2000·Journal of Psychosomatic Research·P BowerM Hann
Jul 8, 2000·Journal of General Internal Medicine·S J BorowskyK B Wells
Jul 31, 2001·The Medical Journal of Australia·S H DownsJ K Peat
May 22, 2002·Annals of Internal Medicine·UNKNOWN U.S. Preventive Services Task Force
May 22, 2002·Annals of Internal Medicine·Michael P PignoneKathleen N Lohr
Jan 25, 2003·BMJ : British Medical Journal·Verena HenkelUlrich Hegerl
Aug 1, 1965·American Sociological Review·L KISH
Jun 12, 2004·The Journal of Pediatrics·Marilyn B EscobedoUNKNOWN Texas Neonatal Research Group

❮ Previous
Next ❯

Citations

Nov 1, 2005·Social Psychiatry and Psychiatric Epidemiology·Sunny Collings, UNKNOWN MaGPIe Research Group
Nov 25, 2011·BMC Family Practice·Weng Yee ChinKit T Y Chan
Mar 12, 2009·The British Journal of General Practice : the Journal of the Royal College of General Practitioners·Dagmar M HallerGeorge C Patton
Jul 11, 2007·The Australian and New Zealand Journal of Psychiatry·Michael Sawyer, Femke Giesen
Nov 24, 2005·Family Practice·John BushnellUNKNOWN MaGPIe Research Group
May 22, 2018·The International Journal of Social Psychiatry·Kai Sing SunDan Wu
Sep 3, 2011·Family Practice·Sunny CollingsSimon Hatcher

❮ Previous
Next ❯

Software Mentioned

Statisical Package for the Social Sciences
SPHERE
Statistical Analysis Software ( SAS )
SAS
CIDI
MaGPIe

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.